ADVERTISEMENT
Posted: Feb 7, 2023

Epinephrine autoinjector myths still common

Allergies

A  November 2022 survey published in the Annals of Allergy, Asthma & Immunology of more than 1,000 adults with food allergies has helped shed light on the challenges patients face with epinephrine autoinjectors (EAIs).

Clarissa Chan, PharmD

Read more
Posted: Feb 7, 2023

CDC releases new pain management guidelines, advocating tailored care for patients

On the Cover

CDC’s updated guidelines on pain management are “a step in the right direction,” said Chris Herndon, PharmD, BCACP, FASHP, FCCP.

Loren Bonner

Read more
Posted: Feb 7, 2023

When cutting costs doesn’t pay

On the Docket

Rising health care costs are a concern for every health care institution. Residential assisted living facilities (RALFs) are among the health care institutions constantly looking for ways to promote efficiency and reduce costs.

David B. Brushwood, BSPharm, JD

Read more
Posted: Feb 7, 2023

Using Vigiv for mpox? The concentration is not as it may seem

Error Alert

A prescriber ordered vaccinia immune globulin intravenous, human (Vigiv–Cangene Corporation) 6,000 units/kg for a hospitalized 3.49 kg neonate (total dose of 20,940 units) with mpox-like symptoms.

Institute for Safe Medication Practices, Horsham, PA

Read more
Posted: Feb 2, 2023

OTC hearing aids bring opportunities for professional collaboration

OTC Hearing Aids

After FDA approval of OTC hearing aids last summer, pharmacies may already be stocking these items.

Sonya Collins

Read more
First3536373840424344Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT